Accelerate to discover
Related topics
Webinar recording: 4D monitoring of bone and (re)modeling events using in vivo micro-CT
Dec 4, 2019
Micro-CT is a powerful tool for the longitudinal monitoring of bones to acquire bone mass and architectural changes in...
Bioflux webinar: Flow dynamics influence on biofilm formation by Proteus mirabilis
Dec 2, 2019
Catheter blockage by ureolytic biofilm-forming pathogens is a significant problem for health services, with 2,000...
Nov 27, 2019
Learn about new SpectroFlo version 2.2.0. Innovative software tools from Cytek Biosciences and De Novo Software that...
Preclinical hyperpolarized carbon-13 magnetic resonance imaging in neurological disease models
Nov 8, 2019
Hyperpolarized (HP)-13C MR is proven as a viable tool for imaging of neurological disorders often associated with...
Imaging Flow Cytometry webinar: aging cells, giant viruses using AMNIS platform
Nov 6, 2019
In this webinar we will describe three recent applications for imaging flow cytometry (IFC), a technology that combines...
Webinar recording: Use of ultra-high field MRI for in and ex vivo neuroimaging
Nov 6, 2019
The relatively low T1 contrast, long T1 values at higher fields lead to the necessity to adapt sequences commonly used...
Join the webcast: Addressing cancer gene therapy efficacy with IncuCyte Live–Cell Imaging
Oct 29, 2019
During this webinar, Dr Pierre Cordelier will discuss the use of IncuCyte Live-Cell Imaging and Analysis, to track gene...
Acquisition and analysis of reproducible high-complexity cytometry data using the Cytek Aurora
Oct 8, 2019
We invite you to join us on Friday, October 11 at 8:00 PM CET to hear more about Cytek collaborative...
Jun 13, 2016
Friday, June 17th, 2016, 5 pm CEST.
High content functional assays that can monitor parameters such as membrane integrity, cytokine release, and more, are critical to understanding target cell response to immunotherapies and allow for rational design of improved therapies.
This webinar will highlight:
- Challenges posed by current methods to screen the efficacy of immunotherapies.
- The need for high content robust tools to evaluate current immunotherapeutic approaches such as adoptive cell therapy, checkpoint blockade etc.
- The ability of the iQue Screener platform to acquire single-cell data on multiple biological readouts in a quantitative, high-throughput fashion and better understand functional efficacy of immuno-oncology therapies.
Get more info
Brand profile
IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.
More info at:
www.intellicyt.com/
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
